Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Lenvatinib Mesylate ( MIBK Solvate) API

Product
  • Therapeutic Category Oncology

  • CAS Number

  • API Technology

    Prostaglandins

  • Dose Form

    Oral Solid/Capsules

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, Brazil DMF, Canada DMF, Korea DMF

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

Dasatinibe

Oncology

arrow

Adagrasib

Oncology

arrow

Fruquintinib

Oncology

arrow

Tucatinib

Oncology

arrow

Ripretinib

Oncology

arrow

Bortezomibe

Oncology

arrow

Cabazitaxel

Oncology

arrow

Cabozantinib HCl

Oncology

arrow

Cabozantinib S-Malate

Oncology

arrow

Capecitabina

Oncology

arrow

Carfilzomib

Oncology

arrow

Decitabina

Oncology

arrow

Deucravacitinib

Oncology

arrow

Mesilato De Eribulina

Oncology

arrow

Lomustina

Oncology

arrow

Cloridrato De Nilotinibe

Oncology

arrow

Olaparib (Form A)

Oncology

arrow

Palbociclibe

Oncology

arrow

Pazopanib

Oncology

arrow

Dissódio Pemetrexede (hepta-hidratado)

Oncology

arrow

Acalabrutinib

Oncology

arrow

Capivasertib

Oncology

arrow

Lenalidomida

Oncology

arrow

Midostaurin

Oncology

arrow

Lenvatinib Mesylate (Form C & MIBK Solvate)

Oncology

arrow

Enzalutamida

Oncology

arrow

Pomalidomida

Oncology

arrow

Gemcitabine Hydrochloride

Oncology

arrow

Abiraterona Acetato

Oncology

arrow

Apalutamide (Amorphous & Form B)

Oncology

arrow

Ácido Zoledrônico

Oncology

arrow

Venetoclax

Oncology

arrow

Azacitidina

Oncology

arrow

Cloridrato De Bendamustina

Oncology

arrow

Relugolix

Oncology

arrow
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.